Tomohiko Ohno Selected Research

Tomohiko Ohno Research Topics

Disease

14	Carcinogenesis 05/2016 - 03/2011
10	Neoplasms (Cancer) 11/2017 - 01/2012
7	Obesity 03/2016 - 03/2011
6	Inflammation (Inflammations) 05/2016 - 06/2011
6	Hepatocellular Carcinoma (Hepatoma) 03/2016 - 10/2012
5	Body Weight (Weight, Body) 07/2014 - 06/2011
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 07/2012
3	Non-alcoholic Fatty Liver Disease 05/2016 - 01/2013
3	Insulin Resistance 01/2015 - 07/2013
2	Liver Neoplasms (Liver Cancer) 03/2016 - 06/2011
2	Adenoma (Adenomas) 03/2016 - 01/2016
2	Aberrant Crypt Foci 07/2014 - 06/2011
2	Malnutrition (Nutritional Deficiencies) 04/2014 - 12/2012
2	Dyslipidemias (Dyslipidemia) 01/2014 - 07/2013
2	Fatty Liver 06/2011 - 03/2011
1	Stomach Neoplasms (Stomach Cancer) 10/2021
1	Diabetes Mellitus 10/2021
1	Atrophic Gastritis 10/2021
1	Type 2 Diabetes Mellitus (MODY) 11/2017
1	Hemorrhage 04/2016
1	Ulcer 01/2016
1	Duodenal Ulcer (Curling's Ulcer) 01/2016
1	Fistula 01/2016
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Melena 01/2016
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2015
1	Lymphoma (Lymphomas) 09/2015
1	Anorexia Nervosa 04/2014
1	Hypertension (High Blood Pressure) 07/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2013
1	Fibrosis (Cirrhosis) 01/2013
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2012
1	Colonic Neoplasms (Colon Cancer) 01/2012
1	Hyperlipidemias (Hyperlipidemia) 06/2011

Drug/Important Bio-Agent (IBA)

7	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 05/2016 - 03/2011
5	AdipokinesIBA 03/2016 - 06/2011
5	Proteins (Proteins, Gene)FDA Link 01/2016 - 03/2011
3	Messenger RNA (mRNA)IBA 03/2016 - 09/2015
3	Tryptophan (L-Tryptophan)FDA Link 01/2016 - 09/2012
3	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2016 - 09/2012
3	3,7,11,15- tetramethyl- 2,4,6,10,14- hexadecapentaenoic acidIBA 01/2014 - 10/2012
2	AntioxidantsIBA 03/2016 - 01/2013
2	AdiponectinIBA 03/2016 - 06/2011
2	EnzymesIBA 01/2016 - 09/2012
2	Bevacizumab (Avastin)FDA Link 01/2016 - 01/2014
2	KynurenineIBA 01/2016 - 09/2015
2	Captopril (Capoten)FDA LinkGeneric 07/2014 - 06/2011
2	AzoxymethaneIBA 07/2014 - 07/2013
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2014 - 06/2011
2	TeaIBA 01/2013 - 03/2011
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 09/2012 - 03/2011
2	Drinking WaterIBA 06/2011 - 03/2011
1	Proton Pump InhibitorsIBA 10/2021
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2017
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2017
1	Glycoside Hydrolase InhibitorsIBA 11/2017
1	Pentoxifylline (Trental)FDA LinkGeneric 05/2016
1	Cyclin D1IBA 03/2016
1	astaxanthine (astaxanthin)IBA 03/2016
1	Granzymes (Granzyme)IBA 01/2016
1	PerforinIBA 01/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2015
1	Insulin (Novolin)FDA Link 01/2015
1	Metformin (Glucophage)FDA LinkGeneric 01/2015
1	TOR Serine-Threonine KinasesIBA 01/2015
1	Antineoplastic Agents (Antineoplastics)IBA 01/2015
1	Antihypertensive Agents (Antihypertensives)IBA 07/2014
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 07/2014
1	Pioglitazone (Actos)FDA Link 04/2014
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2014
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2013
1	Angiotensin IIIBA 07/2013
1	Triglycerides (Triacylglycerol)IBA 01/2013
1	CarcinogensIBA 01/2013
1	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2013
1	Branched-Chain Amino AcidsIBA 12/2012
1	Retinoid X Receptors (Retinoid X Receptor)IBA 10/2012
1	LigandsIBA 10/2012
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2012
1	GW 4064IBA 10/2012
1	Phosphotransferases (Kinase)IBA 07/2012
1	tyrosine receptor (receptor, tyrosine)IBA 07/2012
1	PlatinumIBA 07/2012
1	Cisplatin (Platino)FDA LinkGeneric 07/2012
1	CurcuminIBA 01/2012
1	Interleukin-6 (Interleukin 6)IBA 06/2011
1	LipidsIBA 06/2011
1	pitavastatin (itavastatin)FDA Link 06/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2011
1	Telmisartan (Micardis)FDA Link 06/2011
1	CateninsIBA 06/2011

Therapy/Procedure

8	Chemoprevention 03/2016 - 03/2011
4	Intraperitoneal Injections 01/2016 - 01/2013
2	Subcutaneous Injections 01/2014 - 06/2011
1	Gastrectomy 10/2021
1	Sphincterotomy 04/2016
1	Therapeutics 01/2016
1	Combination Drug Therapy (Combination Chemotherapy) 01/2014